AGC intends to continue to pursue acquisition opportunities and to make capital investments in its synthetic and biopharmaceutical business, expected to exhibit significant growth in demand in the coming years, in order to continue providing customers in every region with globally consistent, top-level quality and service. By maximizing synergies among its sites, AGC will continue to pursue its goal of being a company that contributes to pharmaceutical companies, medical patients, and the wider society in general.
1 CDMO: Contract Development & Manufacturing Organization. A company which is contracted or acts on behalf of another company to handle product manufacturing as well as the development of manufacturing methods.
2 Single-use: Culture tanks that use a disposable vessel.
AGC Inc.(Headquarters: Tokyo, President & CEO: Takuya Shimamura) is the parent company of the AGC Group, a world-leading glass solution provider and supplier of flat, automotive and display glass, chemicals, ceramics and other high-tech materials and components. Based on more than a century of technical innovation, the AGC Group has developed a wide range of cutting-edge products. The AGC Group employs some 50,000 people worldwide and generates annual sales of approximately 1.5 trillion Japanese yen through business in about 30 countries. For more information, please visit
■ AGC Group's Life Science Operations Bases ■